PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
22-Apr-2020 Torx™ - a new web-based platform to keep chemists connected for faster quality candidate selection Torx Software
22-Apr-2020 South Wales business secures £226 million from HSBC UK to support essential industries during Covid-19 HSBC UK
22-Apr-2020 Sobi™ affiliate Florio GmbH, launches a new digital platform aiming to improve the lives of people with haemophilia Sobi
22-Apr-2020 Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting Santhera Pharmaceuticals
22-Apr-2020 AskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative Diseases AskBio
22-Apr-2020 Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 Biovista
22-Apr-2020 Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 Biovista
22-Apr-2020 BlueWillow Biologics® Announces Appointment of Chad Costley, MD, MBA, as Chief Medical Officer BlueWillow Biologics
22-Apr-2020 BlueWillow Biologics® Announces Appointment of Chad Costley, MD, MBA, as Chief Medical Officer BlueWillow Biologics
22-Apr-2020 BlueWillow Biologics® Announces Appointment of Chad Costley, MD, MBA, as Chief Medical Officer BlueWillow Biologics
22-Apr-2020 Lonza to Host New Webinar – "3D Cell Culture Models for Respiratory Research" Lonza
22-Apr-2020 CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers CytoSMART
22-Apr-2020 Sense Appoints John Bishop to its Board of Directors Sense Biodetection Limited
22-Apr-2020 Sobi(TM) Affiliate Florio GmbH, Launches a New Digital Platform Aiming to Improve the Lives of People with Haemophilia Swedish Orphan Biovitrum AB
22-Apr-2020 FoRx Therapeutics AG Raises EUR 10 Million Seed Round and Becomes First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer FoRx Therapeutics AG
22-Apr-2020 Actinium Pharmaceuticals, Inc. Announces Pricing of $27.5 Million Public Offering Actinium Pharmaceuticals, Inc.
21-Apr-2020 Seegene's Allplex(TM) 2019-nCoV Assay receives FDA Emergency Use Authorization Seegene
21-Apr-2020 Invitae to announce first quarter 2020 financial results on May 5, 2020 Invitae Corporation
21-Apr-2020 Actinium Pharmaceuticals, Inc. Announces Proposed Public Offering Actinium Pharmaceuticals, Inc.
21-Apr-2020 Immunic, Inc. Reports that IMU-838, a Selective Oral DHODH Inhibitor, Has Demonstrated Preclinical Activity Against SARS-CoV-2 and Explores Plans for a Phase 2 Clinical Trial in COVID-19 Patients Immunic, Inc.